Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsPeripheral Blood Stem Cell TransplantationTransplantation, AutologousGraft vs Host DiseaseHematopoietic Stem Cell TransplantationBone and BonesWhole-Body IrradiationTransplantation ConditioningHematopoietic Stem CellsLeukemiaAnemia, AplasticTissue DonorsGraft SurvivalHematopoietic Stem Cell MobilizationHematologic NeoplasmsTransplantation ChimeraBusulfanHistocompatibility TestingBone Marrow PurgingGranulocyte Colony-Stimulating FactorCyclophosphamideHistocompatibilityBone Marrow DiseasesCombined Modality TherapyHematopoiesisRecurrenceAntigens, CD34Treatment OutcomeImmunosuppressive AgentsTransplantation, IsogeneicLeukapheresisLeukemia, Myeloid, AcuteTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsBone Marrow ExaminationLymphoma, Non-HodgkinMice, Inbred C57BLBone RemodelingPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionKidney TransplantationImmunosuppressionStem CellsStem Cell TransplantationMelphalanBone Marrow NeoplasmsRadiation ChimeraRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesGraft RejectionLymphocyte DepletionColony-Forming Units AssayLiver TransplantationMultiple MyelomaBlood CellsAcute DiseaseCyclosporineBlood Component RemovalSurvival AnalysisLeukemia, MyeloidHematologic DiseasesHLA AntigensMyelodysplastic SyndromesLeukocyte TransfusionLeukocyte CountOpportunistic InfectionsFlow CytometryNuclear FamilyHepatic Veno-Occlusive DiseaseGraft vs Host ReactionBone DensitySurvival RateDisease-Free SurvivalTransplantation ImmunologyImmunocompromised HostFatal OutcomeCells, CulturedLymphocyte TransfusionBlood Cell CountCell DifferentiationCord Blood Stem Cell TransplantationInfectionEtoposideChimeraFollow-Up StudiesHodgkin DiseaseImmunophenotypingCell SeparationBone ResorptionLymphomaSevere Combined ImmunodeficiencyCytarabineGranulocytesBlood Group IncompatibilityPolymerase Chain Reaction